Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior
Open accessThe DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Abstract
Hypocretin-1 and -2 (Hcrt-1 and Hcrt-2), also referred to as orexin-A and -B, are neuropeptides synthesized by a few thousand neurons in the lateral hypothalamus. Hypocretin-containing neurons project throughout the brain, with a prominent input to basal forebrain structures involved in motivation, reward, and stress. However, the role of hypocretins in addiction-related behaviors remains largely unexplored. Here we show that intracerebroventricular infusions of Hcrt-1 lead to a dose-related reinstatement of cocaine seeking without altering cocaine intake in rats. Hcrt-1 also dramatically elevates intracranial self-stimulation thresholds, indicating that, unlike treatments with reinforcing properties such as cocaine, Hcrt-1 negatively regulates the activity of brain reward circuitries. Hypocretin-induced reinstatement of cocaine seeking was prevented by blockade of noradrenergic and corticotropin-releasing factor systems, suggesting that Hcrt-1 reinstated drug seeking through induction of a stress-like state. Consistent with this interpretation, the selective Hcrt-1 receptor antagonist SB-334867 blocked footshock-induced reinstatement of previously extinguished cocaine-seeking behavior. These findings reveal a previously unidentified role for hypocretins in driving drug seeking through activation of stress pathways in the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Additional studies demonstrate that intraventricular Hcrt-1 elevates intracranial self-stimulation thresholds, suggesting an aversive effect of excessive activation of the Hcrt system (Boutrel et al., 2005).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Boutrel et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
A stereotaxic atlas of the rat brain
Pellegrino, L. J., & Cushman, A. J. (1967) · Plenum Press eBooks · Cited by 4,688
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P. J., Nishino, S., & Mignot, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81965-0 · Cited by 2,613
Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R., et al. (2000) · Nature Medicine · doi:10.1038/79690 · Cited by 2,118
Reduced Number of Hypocretin Neurons in Human Narcolepsy
Thannickal, T. C., Moore, R. Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M., & Siegel, J. M. (2000) · Neuron · doi:10.1016/s0896-6273(00)00058-1 · Cited by 2,089
Shaffer, J. P. (1995) · Annual Review of Psychology · doi:10.1146/annurev.ps.46.020195.003021 · Cited by 1,960
Research works printed but not linked: 5
- 10.1097/00075197-200307000-00001 · doi:10.1097/00075197-200307000-00001
- Boutrel, B., Kenny, P. J., Markou, A. & Koob, G. F. (2005) in Hypocretins: Integrators of Physiological Functions, eds. de Lecea, L. & Sutcliffe, J. G. (Springer, New York), pp. 315-324.
- Kornetsky, C. & Esposito, R. U. (1979) Fed. Proc. 38**,** 2473-2476. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/488370/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Fed.%20Proc.&volume=38&publication_year=1979&pages=2473&pmid=488370&)]
- 10.1037/1064-1297.6.3.255 · doi:10.1037/1064-1297.6.3.255
- Horvath, T. L., Peyron, C., Diano, S., Ivanov, A., Aston-Jones, G., Kilduff, T. S. & van den Pol, A. N. (1999) J. Comp. Neurol. 415**,** 145-159. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/10545156/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=J.%20Comp.%20Neurol.&volume=415&publication_year=1999&pages=145&pmid=10545156&)] · doi:10.1002/(sici)1096-9861(19991213)415:2<145::aid-cne1>3.0.co;2-2
Cited by
The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
Sakurai, T. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2092 · Cited by 1,276
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056
“Antagonism of OX1 receptors prevented footshock-induced reinstatement of cocaine-seeking behavior in rats (Boutrel et al., 2005).”
InfluentialSelf-citationHomeostatic and hedonic signals interact in the regulation of food intake
Lutter, M., & Nestler, E. J. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.097618 · Cited by 614
Arousal and reward: a dichotomy in orexin function
Harris, G. C., & Aston-Jones, G. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.08.002 · Cited by 565
“Boutrel et al. [ 30 ] found that intracerebroventricular (icv) infusion of orexin produces a dose-related reinstatement of extinguished cocaine self-administration in rats, an effect that was prevented by antagonists of noradrenaline or CRF receptors.”
BackgroundOrexin/Hypocretin: A Neuropeptide at the Interface of Sleep, Energy Homeostasis, and Reward System
Tsujino, N., & Sakurai, T. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001321 · Cited by 479
“…suggested further roles for orexin in the coordination of emotion, energy homeostasis, reward, drug addiction, and arousal (Yamanaka et al., 2003a; Akiyama et al., 2004; Mieda et al., 2004a; Boutrel et al., 2005; Harris et al., 2005; Sakurai et al., 2005; Narita et al., 2006; Yoshida et al., 2006).”
BackgroundInfluentialThe role of orexin in motivated behaviours
Sakurai, T. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3837 · Cited by 464
Stress-induced reinstatement of drug seeking: 20 years of progress
Mantsch, J. R., Baker, D. A., Funk, D., Lê, A. D., & Shaham, Y. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.142 · Cited by 438
The neurocircuitry of addiction: an overview
Feltenstein, M. W., & See, R. E. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.51 · Cited by 421
“, 2005), including the reinstatement of cocaine (Boutrel et al., 2005) and alcohol (Lawrence et al.”
BackgroundGoodman, A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.030 · Cited by 413
Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction
Aston-Jones, G., Smith, R. J., Sartor, G. C., Moorman, D. E., Massi, L., Tahsili-Fahadan, P., & Richardson, K. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.106 · Cited by 389
“Evidence supporting the latter comes from findings that reinstatement of cocaineseeking induced by intracerebroventricular administration of orexin was blocked by NE and CRF antagonists (Boutrel et al., 2005 ).”
InfluentialThe orexin system regulates alcohol-seeking in rats
Lawrence, A. J., Cowen, M. S., Yang, H., Chen, F., & Oldfield, B. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706789 · Cited by 392
“Given the recent findings relating to orexin systems and drug-seeking (Boutrel et al., 2005; Harris et al., 2005), the ability of orexins to interact with CRF and/or NPY systems may be of relevance to alcoholism.”
BackgroundOrexin A/Hypocretin-1 Selectively Promotes Motivation for Positive Reinforcers
Borgland, S. L., Chang, S.-J., Bowers, M. S., Thompson, J. L., Vittoz, N., Floresco, S. B., Chou, J., Chen, B. T., & Bonci, A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.6096-08.2009 · Cited by 341
“Further, reinstatement to cocaine (Harris et al., 2005; Boutrel et al., 2006; Smith et al., 2009) or ethanol (Lawrence et al., 2006), and the development of behavioral sensitization to cocaine (Borgland et al., 2006), is blocked by the ox/hcrt-1R antagonist, SB334867.”
BackgroundDrug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
“Additional studies demonstrate that intraventricular Hcrt-1 elevates intracranial self-stimulation thresholds, suggesting an aversive effect of excessive activation of the Hcrt system (Boutrel et al., 2005).”
BackgroundSelf-citationRole of lateral hypothalamic orexin neurons in reward processing and addiction
Aston-Jones, G., Smith, R. J., Moorman, D. E., & Richardson, K. A. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.060 · Cited by 322
Insular hypocretin transmission regulates nicotine reward
Hollander, J. A., Lu, Q., Cameron, M. D., Kamenecka, T. M., & Kenny, P. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808023105 · Cited by 296
Self-citationControl of hypothalamic orexin neurons by acid and CO 2
Williams, R. H., Jensen, L. T., Verkhratsky, A., Fugger, L., & Burdakov, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702676104 · Cited by 291
Orexin neuronal circuitry: Role in the regulation of sleep and wakefulness
Ohno, K., & Sakurai, T. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.08.001 · Cited by 274
“ICV or local VTA infusion of orexin drives behavior motivated by either food or drug rewards [104,13,48].”
BackgroundInfluentialMuschamp, J. W., Hollander, J. A., Thompson, J. L., Voren, G., Hassinger, L. C., Onvani, S., Kamenecka, T. M., Borgland, S. L., Kenny, P. J., & Carlezon, W. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315542111 · Cited by 256
Self-citationInutsuka, A., & Yamanaka, A. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00018 · Cited by 235
“Past studies also revealed roles for orexin neurons beyond feeding and arousal, including autonomic nervous system control (Sellayah et al., 2011; Tupone et al., 2011) and in reward and stress systems (Boutrel et al., 2005; Harris et al., 2005).”
BackgroundInfluentialEspaña, R. A., Oleson, E. B., Locke, J. L., Brookshire, B. R., Roberts, D. C. S., & Jones, S. R. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07065.x · Cited by 250
“This dose of SB-334867 has previously been used to successfully block reinstatement of cocaine-seeking (Boutrel et al., 2005) and CPP for morphine (Harris et al., 2005).”
BackgroundInfluentialRole of orexin in modulating arousal, feeding, and motivation
Tsujino, N., & Sakurai, T. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00028 · Cited by 255
“Moreover, icv or local VTA infusion of orexin was shown to reinstate drug-seeking or food-seeking behavior in rodents (Boutrel et al., 2005; Harris et al., 2005).”
BackgroundThe hypocretins/orexins: integrators of multiple physiological functions
Li, J., Hu, Z., & de Lecea, L. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12415 · Cited by 244
“British Journal of Pharmacology (2014) 171 332–350 337 The functional role of orexin in the reward process was demonstrated by Boutrel et al. (2005), who showed that i.c.v. infusion of orexin-A elevated intracranial self-stimulation thresholds in rats, which suggests that it decreases brain reward…”
BackgroundGiardino, W. J., Eban-Rothschild, A., Christoffel, D. J., Li, S.-B., Malenka, R. C., & de Lecea, L. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0198-x · Cited by 252
The roles of the reward system in sleep and dreaming
Perogamvros, L., & Schwartz, S. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.05.010 · Cited by 239
Modafinil for the treatment of cocaine dependence
Anderson, A. L., Reid, M. S., Li, S.-H., Holmes, T., Shemanski, L., Slee, A., Smith, E. V., Kahn, R., Chiang, N., Vocci, F., et al. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.015 · Cited by 235
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript administration in rats (Boutrel et al., 2005).”
Richards, J. K., Simms, J. A., Steensland, P., Taha, S. A., Borgland, S. L., Bonci, A., & Bartlett, S. E. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1136-5 · Cited by 234
“Orexin-A/hypocretin-1 has been shown to induce noradrenaline release (Hirota et al. 2001) and orexin-A/hypocretin-1 induced reinstatement of cocaine seeking has been blocked using CRF-1 and noradrenergic receptor antagonists (Boutrel et al. 2005).”
InfluentialEllis, J., Pediani, J. D., Canals, M., Milasta, S., & Milligan, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602494200 · Cited by 225
Dayas, C. V., McGranahan, T. M., Martin-Fardon, R., & Weiss, F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.02.002 · Cited by 224
Self-citationRole of orexin/hypocretin in reward-seeking and addiction: Implications for obesity
Cason, A. M., Smith, R. J., Tahsili-Fahadan, P., Moorman, D. E., Sartor, G. C., & Aston-Jones, G. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.03.009 · Cited by 229
“Taken together with previous findings that SB reduced stress- or yohimbine-induced reinstatement of ethanolor sucrose-seeking [41,69], these results indicate that orexinmight play a general role in reward-seeking elicited by reward-conditioned stimuli.”
ResultSakurai, T., & Mieda, M. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.03.007 · Cited by 220
“OXR-2 SORA 1-(2-bromo-phenyl)-3-((4S,5S)-2,2dimethyl-4-phenyl-[1,3]dioxan-5-yl)-urea 5.”
Orexin/hypocretin signaling at the orexin 1 receptor regulates cue‐elicited cocaine‐seeking
Smith, R. J., See, R. E., & Aston‐Jones, G. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06844.x · Cited by 218
The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Wang, C., Wang, Q., Ji, B., Pan, Y., Xu, C., Cheng, B., Bai, B., & Chen, J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00220 · Cited by 207
Housekeeping and tissue-specific genes in mouse tissues
Kouadjo, K. E., Nishida, Y., Cadrin-Girard, J. F., Yoshioka, M., & St-Amand, J. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-127 · Cited by 206
“Studies have hinted at a role of hypocretins in driving drug-seeking through activation of stress pathways in the brain [68].”
BackgroundMultiple roles for orexin/hypocretin in addiction
Mahler, S. V., Smith, R. J., Moorman, D. E., Sartor, G. C., & Aston-Jones, G. (2012) · Progress in Brain Research · doi:10.1016/b978-0-444-59489-1.00007-0 · Cited by 215
“…was observed for cocaine, where SB-334867 blocked footshock-induced reinstatement and a CRF antagonist blocked orexininduced reinstatement (described above) (Boutrel et al., 2005), further emphasizing the point that orexin appears to play unique roles in addiction depending upon the type of drug.”
InfluentialSmith, R. J., & Aston-Jones, G. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0191-3 · Cited by 206
“In addition, the OX1 receptor antagonist SB-334867 blocked stress-induced reinstatement of cocaine-seeking (Boutrel et al. 2005).”
BackgroundThe orexin system: roles in sleep/wake regulation
Sakurai, T., Mieda, M., & Tsujino, N. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05513.x · Cited by 200
James, M. H., Stopper, C. M., Zimmer, B. A., Koll, N. E., Bowrey, H. E., & Aston-Jones, G. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.07.022 · Cited by 193
HARRIS, G., WIMMER, M., RANDALLTHOMPSON, J., & ASTONJONES, G. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.05.025 · Cited by 198
“[4] Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, Koob GF, de Lecea L.”
BackgroundA Role for Hypocretin (Orexin) in Male Sexual Behavior
Muschamp, J. W., Dominguez, J. M., Sato, S. M., Shen, R.-Y., & Hull, E. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4121-06.2007 · Cited by 193
“At a dose similar to those used to block stressinduced reinstatement of cocaine self-administration (Boutrel et al., 2005), SB 334867 significantly increased intromission latency and decreased numbers of ejaculations, suggesting that blockade of hcrt/orx transmission may affect the incentive…”
BackgroundResultInfluentialZhao, Y., Dayas, C. V., Aujla, H., Baptista, M. A. S., Martin-Fardon, R., & Weiss, F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2384-06.2006 · Cited by 192
“, 2004), and lateral hypothalamus (Boutrel et al., 2005) contributed in some manner to the “anti-reinstatement” actions of the mGlu2/3 agonist.”
BackgroundSelf-citationThe neural correlates and role of D1 dopamine receptors in renewal of extinguished alcohol-seeking
Hamlin, A. S., Newby, J., & McNally, G. P. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.01.063 · Cited by 185
“Moreover, systemic injections of orexin receptor antagonist SB-334867 prevent cue-induced reinstatement of extinguished alcohol-seeking (Lawrence et al., 2006) and stress-induced reinstatement of extinguished cocaineseeking ( Boutrel et al., 2005 ).”
Orexin/hypocretin role in reward: implications for opioid and other addictions
Baimel, C., Bartlett, S. E., Chiou, L., Lawrence, A. J., Muschamp, J. W., Patkar, O., Tung, L., & Borgland, S. L. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12639 · Cited by 179
“…reinstatement of ethanol seeking and relapse The orexin system plays a role in response to stress and orexin neurons are activated in response to arousal, which is a key component of the stress response system (Winsky-Sommerer et al., 2004; Boutrel et al., 2005; Richards et al., 2008).”
BackgroundTobacco addiction and the dysregulation of brain stress systems
Bruijnzeel, A. W. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.02.015 · Cited by 173
“More recent studies have provided evidence for a role of neuropeptide Y and the hypocretins in the regulation of mood states and drug addiction (Boutrel et al., 2005; Gilpin et al., 2003).”
BackgroundHypocretin/orexin in arousal and stress
Berridge, C. W., España, R. A., & Vittoz, N. M. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.019 · Cited by 172
A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
James, M. H., Mahler, S. V., Moorman, D. E., & Aston-Jones, G. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_57 · Cited by 171
“Soon after, Boutrel and colleagues reported that central infusions of orexin peptide reinstate extinguished cocaine seeking and systemic injections of the Ox1R antagonist block cocaine seeking elicited by stress [19].”
Kily, L. J. M., Cowe, Y. C. M., Hussain, O., Patel, S., McElwaine, S., Cotter, F. E., & Brennan, C. H. (2008) · Journal of Experimental Biology · doi:10.1242/jeb.014399 · Cited by 170
España, R. A., Melchior, J. R., Roberts, D. C. S., & Jones, S. R. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2048-8 · Cited by 169
“…across multiple self-administration procedures (Borgland et al. 2009; España et al. 2010), blocks reinstatement of cocaine-seeking (Aston-Jones et al. 2009; Boutrel et al. 2005; Harris et al. 2005; Smith et al. 2009, 2010), and decreases behavioral sensitization to cocaine (Borgland et al. 2006).”
BackgroundResultInfluentialActivation of Central Orexin/Hypocretin Neurons by Dietary Amino Acids
Karnani, M. M., Apergis-Schoute, J., Adamantidis, A., Jensen, L. T., de Lecea, L., Fugger, L., & Burdakov, D. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.027 · Cited by 168
“Interestingly, there is accumulating evidence that underactivity and overactivity of the orx/hcrt system may lead to depression and anxiety, respectively (Boutrel et al., 2005; Brundin et al., 2007; Ito et al., 2008; Suzuki et al., 2005).”
Renewal of extinguished cocaine-seeking
Hamlin, A. S., Clemens, K. J., & McNally, G. P. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.018 · Cited by 164
Gotter, A. L., Webber, A. L., Coleman, P. J., Renger, J. J., & Winrow, C. J. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005546 · Cited by 162
Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking
Shalev, U., Erb, S., & Shaham, Y. (2010) · Brain Research · doi:10.1016/j.brainres.2009.07.028 · Cited by 153
“In an initial study, Boutrel et al. (2005) reported that systemic injections of SB 334867 (a hypocretin type 1 receptor antagonist) attenuated footshock stress-induced reinstatement of cocaine seeking.”
BackgroundPlaza-Zabala, A., Martín-García, E., de Lecea, L., Maldonado, R., & Berrendero, F. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5724-09.2010 · Cited by 157
“The dose selected for Hcrt-1 infusion was based on previous studies (Boutrel et al., 2005; Nair et al., 2008).”
BackgroundMethodResultShoblock, J. R., Welty, N., Aluisio, L. E., Fraser, I. C., Motley, S. T., Morton, K. L., Palmer, J. A., Bonaventure, P., Carruthers, N. I., Lovenberg, T. W., et al. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2127-x · Cited by 167
“Several previous studies tested only a single high dose of SB-334867 (20 or 30 mg/kg i.p.) or reported maximum effects at high doses (20–30 mg/kg i.p.; Boutrel et al. 2005; Harris et al. 2005; Lawrence et al. 2006; Richards et al. 2008; Sakurai et al. 1998; Sharf et al. 2008).”
BackgroundResultInfluentialPiccoli, L., Bonaventura, M. V. M. D., Cifani, C., Costantini, V. J. A., Massagrande, M., Montanari, D., Martinelli, P., Antolini, M., Ciccocioppo, R., Massi, M., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.48 · Cited by 160
Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction
Forget, B., Pushparaj, A., & Le Foll, B. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.029 · Cited by 153
Inhibitory Interplay between Orexin Neurons and Eating
González, J. A., Jensen, L. T., Iordanidou, P., Strom, M., Fugger, L., & Burdakov, D. (2016) · Current Biology · doi:10.1016/j.cub.2016.07.013 · Cited by 152
“In humans and rodents, loss of brain orexin/hypocretin (OH) neurons causes pathological sleepiness [1–4], whereas OH hyperactivity is associated with stress and anxiety [5–10].”
BackgroundMahler, S. V., & Aston-Jones, G. S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2277-12.2012 · Cited by 145
“…preference and seeking, and orexin is necessary for discrete and contextual cue-induced reinstatement of cocaine seeking, including orexin in VTA (Boutrel et al., 2005; Harris et al., 2005; Smith et al., 2009; Wang et al., 2009; Smith et al., 2010; Mahler et al., 2012a,b; Smith and Aston-Jones,…”
BackgroundSharf, R., Sarhan, M., & Dileone, R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.006 · Cited by 155
“Additional evidence for the possible role of orexin in negative reinforcement comes from studies in which central administration of the orexin A neuropeptide reinstates extinguished lever pressing for both cocaine and food as well as raising intracranial selfstimulation thresholds (43).”
BackgroundStructure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors
Yin, J., Babaoglu, K., Brautigam, C. A., Clark, L. D., Shao, Z., Scheuermann, T. H., Harrell, C. M., Gotter, A. L., Roecker, A. J., Winrow, C. J., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3183 · Cited by 159
Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons
Borgland, S. L., Storm, E., & Bonci, A. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06397.x · Cited by 141
“…⁄ hcrt-1) and orexin B ⁄ hypocretin 2 (oxB ⁄ hcrt-2), have also been implicated in arousal, feeding and reward (DeLecea et al. , 1998; Sakurai et al. , 1998; Georgescu et al. , 2003; Yamanaka et al. , 2003; Boutrel et al. , 2005; Harris et al. , 2005; Borgland et al. , 2006; Narita et al. , 2006).”
BackgroundJames, M. H., Charnley, J. L., Levi, E. M., Jones, E., Yeoh, J. W., Smith, D. W., & Dayas, C. V. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000423 · Cited by 141
Mahler, S. V., Smith, R. J., & Aston-Jones, G. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2681-5 · Cited by 140
“2009, Smith 2010), and stress-induced reinstatement of cocaine and ethanol seeking (Boutrel et al. 2005; Richards et al. 2008).”
Role of cues and contexts on drug‐seeking behaviour
Perry, C. J., Zbukvic, I., Kim, J. H., & Lawrence, A. J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12735 · Cited by 130
“British Journal of Pharmacology (2014) 171 4636–4672 4649 Table 4 Opiate-seeking behaviour: effect of pharmacological agents on cue-, stress- and drug-primed reinstatement System Reference Cue Stress Prime Adenosine receptors A2A receptor antagonist DMPX Yao et al., 2006 Decreased Adrenoceptors α2 adrenoceptor agonist…”
BackgroundPhysiology of the orexinergic/hypocretinergic system: a revisit in 2012
Kukkonen, J. P. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00227.2012 · Cited by 146
“A number of studies [initially in (43, 134)] show a role for orexins in addiction, and possibly in motivation/reward/reinforcement-linked processes [reviewed in (17, 42, 60, 353)].”
BackgroundJupp, B., Krivdic, B., Krstew, E., & Lawrence, A. J. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.045 · Cited by 141
“…the batch of SB-334867 used gave a reduction in ethanol responding of approximately 75% at a dose of only 5 mg/kg. Importantly, all of these doses fall within the range that has previously been demonstrated to be effective in vivo (Boutrel et al., 2005; Harris et al., 2005; Richards et al., 2008).”
Grafe, L. A., & Bhatnagar, S. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.06.003 · Cited by 130
Engel, J. A., & Jerlhag, E. (2014) · CNS Drugs · doi:10.1007/s40263-014-0178-y · Cited by 132
“Central administration of orexin reinstates cocaine, morphine as well as heroin seeking behavior [128–130].”
BackgroundWang, B., You, Z.-B., & Wise, R. A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.018 · Cited by 134
Millan, E. Z., Marchant, N. J., & McNally, G. P. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.10.037 · Cited by 150
Nair, S. G., Golden, S. A., & Shaham, Y. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.3 · Cited by 132
“…this possibility is unlikely since the number of active lever presses in our reinstatement tests after exposure to hypocretin 1, pellet-priming and yohimbine are comparable to previous studies where SB 334867 decreased reinstatement of drug seeking (Boutrel et al., 2005; Lawrence et al., 2006).”
BackgroundMethodResultInfluentialThe Hypocretin/Orexin System Mediates the Extinction of Fear Memories
Flores, Á., Valls-Comamala, V., Costa, G., Saravia, R., Maldonado, R. J., & Berrendero, F. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.146 · Cited by 141
“These doses were based on previous studies (Plaza-Zabala et al, 2012; Boutrel et al, 2005).”
Hcrtr1 and 2 signaling differentially regulates depression-like behaviors
Scott, M. M., Marcus, J. N., Pettersen, A., Birnbaum, S. G., Mochizuki, T., Scammell, T. E., Nestler, E. J., Elmquist, J. K., & Lutter, M. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.02.044 · Cited by 133
“Furthermore, our data also illustrate how a negative emotional state along with the development of anhedonia (based on other reports [8]) may be enhanced, through disruption of hcrtr2 signaling, leaving hcrtr1 transmission intact.”
BackgroundResultInfluentialOrexin/hypocretin is necessary for context-driven cocaine-seeking
Smith, R. J., Tahsili-Fahadan, P., & Aston-Jones, G. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.042 · Cited by 131
“SB blocked cue- and stressinduced reinstatement of extinguished drug-seeking for cocaine and ethanol in the self-administration paradigm (Boutrel et al., 2005; Lawrence et al., 2006; Richards et al., 2008; Smith et al., in press).”
BackgroundZhou, Y., Bendor, J., Hofmann, L., Randesi, M., Ho, A., & Kreek, M. J. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06960 · Cited by 127
“0$05.”
BackgroundInfluentialTo eat or to sleep: That is a lateral hypothalamic question
Arrigoni, E., Chee, M. J. S., & Fuller, P. M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.017 · Cited by 134
The discovery of suvorexant, the first orexin receptor drug for insomnia
Coleman, P. J., Gotter, A. L., Herring, W. J., Winrow, C. J., & Renger, J. J. (2017) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104837 · Cited by 128
The role of hypocretin in driving arousal and goal-oriented behaviors
Boutrel, B., Cannella, N., & de Lecea, L. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.054 · Cited by 138
“…brain reward pathways has sparked a great deal of interest in the construct of arousal and hyperarousal (Borgland et al., 2006; Boutrel et al., 2005; Carr and Kalivas, 2006; Georgescu et al., 2003; Harris et al., 2005; Hollander et al., 2008; Lawrence, this issue; Narita et al., 2006; Wise 2006 ).”
BackgroundSelf-citationHsu, D. T., & Price, J. L. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.21934 · Cited by 127
“ORX has also been shown to play a role in reward-seeking behavior, drug relapse and addiction (Harris et al., 2005), and in mediating stress-induced reinstatement of drug-seeking behavior (Boutrel et al., 2005).”
BackgroundTung, L., Lu, G.-L., Lee, Y., Yu, L., Lee, H.-J., Leishman, E., Bradshaw, H., Hwang, L., Hung, M.-S., Mackie, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms12199 · Cited by 116
“This discrepancy may be explained as in the study of Boutrel et al. 15 , SB-334867 was given by systemic injection and orexin receptors in the brain regions other than the VTA may be involved 44 .”
Smith, R. J., & Aston‐Jones, G. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08013.x · Cited by 121
Morairty, S. R., Revel, F. G., Malherbe, P., Moreau, J.-L., Valladao, D., Wettstein, J. G., Kilduff, T. S., & Borroni, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039131 · Cited by 121
“Other studies have suggested roles for the HCRT system in neuroendocrine, cardiovascular, water balance, and gastrointestinal control [14], nociception and hyperalgesia [15,16,17], stress and stress-induced analgesia [18,19], reward and addiction [20,21,22,23], and panic anxiety [24].”
Adaptive sugar sensors in hypothalamic feeding circuits
Williams, R. H., Alexopoulos, H., Jensen, L. T., Fugger, L., & Burdakov, D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802687105 · Cited by 122
Ouzir, M., & Errami, M. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.06.005 · Cited by 132
Logrip, M. L., Zorrilla, E. P., & Koob, G. F. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.007 · Cited by 117
Self-citationMedial Dorsal Hypothalamus Mediates the Inhibition of Reward Seeking after Extinction
Marchant, N. J., Furlong, T. M., & McNally, G. P. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4079-10.2010 · Cited by 114
“For example, hypothalamic orexin neurons are important for reinstatement of extinguished drug-seeking (Boutrel et al., 2005; Harris et al., 2005; Lawrence et al., 2006) and inactivation of LH prevents context-induced reinstatement of extinguished alcoholic beer seeking (Marchant et al.”
BackgroundPharmacotherapy of Methamphetamine Addiction: An Update
Elkashef, A., Vocci, F., Hanson, G., White, J., Wickes, W., & Tiihonen, J. (2008) · Substance Abuse · doi:10.1080/08897070802218554 · Cited by 120
Beuckmann, C. T., Suzuki, M., Ueno, T., Nagaoka, K., Arai, T., & Higashiyama, H. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.241422 · Cited by 123
“…system is involved in many physiologic functions, among them sleep/wake control (Chemelli et al., 1999), feeding (Sakurai et al., 1998), energy homeostasis (Hara et al., 2001; Yamanaka et al., 2003), and reward seeking (Boutrel et al., 2005; Harris et al., 2005), to name the most prominent ones.”
BackgroundThe intersection of stress and reward: BNST modulation of aversive and appetitive states
Ch'ng, S., Fu, J., Brown, R. M., McDougall, S. J., & Lawrence, A. J. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.01.005 · Cited by 112
“Inhibition of OX1R signalling prevents stress-induced reinstatement of sucrose, alcohol and cocaine seeking (Boutrel et al., 2005; Richards et al., 2008; Buffalari and See, 2011; Zhou et al., 2011).”
Sarchielli, P., Rainero, I., Coppola, F., Rossi, C., Mancini, M. L., Pinessi, L., & Calabresi, P. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01566.x · Cited by 117
Orexin Neurons Are Necessary for the Circadian Control of REM Sleep
Kantor, S., Mochizuki, T., Janisiewicz, A. M., Clark, E., Nishino, S., & Scammell, T. E. (2009) · Sleep · doi:10.1093/sleep/32.9.1127 · Cited by 111
A role for hypocretin/orexin in motivation
Thompson, J. L., & Borgland, S. L. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.09.028 · Cited by 118
The role of the orexin system in stress response
Sargin, D. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.034 · Cited by 105
Martin-Fardon, R., Zorrilla, E. P., Ciccocioppo, R., & Weiss, F. (2010) · Brain Research · doi:10.1016/j.brainres.2009.12.027 · Cited by 112
“…in the BNST. Consistent with this hypothesis are recent findings showing that SB334867 attenuates stress-induced reinstatement of cocaine seeking (Boutrel et al., 2005) and that Orx-A/Hcrt-1-induced reinstatement of cocaine seeking is reversed by intracerebroventricular administration of the…”
InfluentialSelf-citationThe hypocretins as sensors for metabolism and arousal
Adamantidis, A., & De Lecea, L. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.164400 · Cited by 112
“More importantly, the Hcrt system mediates stress-induced reinstatement of cocaine-seeking behaviour (Boutrel et al. 2005).”
BackgroundNair, S. G., Adams-Deutsch, T., Epstein, D. H., & Shaham, Y. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.05.003 · Cited by 112
Abnormal activity in reward brain circuits in human narcolepsy with cataplexy
Ponz, A., Khatami, R., Poryazova, R., Werth, E., Boesiger, P., Bassetti, C. L., & Schwartz, S. (2010) · Annals of Neurology · doi:10.1002/ana.21825 · Cited by 110
Lateral Hypothalamus Is Required for Context-Induced Reinstatement of Extinguished Reward Seeking
Marchant, N. J., Hamlin, A. S., & McNally, G. P. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5194-08.2009 · Cited by 109
“…place preference (Harris et al., 2005) whereas the orexin antagonist SB 334867 prevents cue or yohimbine induced reinstatement of extinguished alcohol seeking (Lawrence et al., 2006; Richards et al., 2008) as well as stress induced reinstatement of cocaine seeking (Boutrel et al., 2005).”
BackgroundSleep and metabolism: shared circuits, new connections
Adamantidis, A., & de Lecea, L. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.08.007 · Cited by 122
Role of orexin/hypocretin in dependence and addiction
Sharf, R., Sarhan, M., & Dileone, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.028 · Cited by 117
Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand?
Hoyer, D., & Jacobson, L. H. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.009 · Cited by 116
“…model used e.g. ICSS (intra cranial self-stimulation) versus infusion in progressive ratio studies, suggesting differences in behavior depending on the level of effort needed to access the drug (for recent reviews see Kenny, 2011; Boutrel et al., 2005, 2010, 2013; Kim et al., 2012).”
Method
Metadata
- Authors
- Boutrel, B., Kenny, P. J., Specio, S. E., Martin-Fardon, R., Markou, A., Koob, G. F., & de Lecea, L.
- Affiliations
- Scripps Research Institute (US)
- Center for Psychiatric Neuroscience and Service Universitaire de Psychiatrie de l'Enfant et de l'Adolescent (SUPEA), Centre Hospitalier Universitaire Vaudois-Département de Psychiatrie (CHUV-DP), University of Lausanne, CH-1008 Prilly, Switzerland; and Departments of Molecular Biology and Molecular and Integrative Neurosciences, The Scripps Research Institute, La Jolla, CA 92037
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-12-15
- Volume
- 102
- Issue
- 52
- Pages
- 19168-19173
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1323172
- OpenAlex
- W2098772655
- Cited by
- 520
- References
- 48
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 18 · 2023: 15 · 2022: 15 · 2021: 13 · 2020: 16 · 2019: 13 · 2018: 30 · 2017: 17 · 2016: 27 · 2015: 29 · 2014: 38 · 2013: 33 · 2012: 47
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (1r21aa013241-01)
- National Institute on Alcohol Abuse and Alcoholism (AA13241)
- National Institute of Mental Health (R01MH058543, MH 58543)
- National Institute on Drug Abuse (DA07348, R01DA007348, DA04398, DA 11946, R37DA007348, R56DA011946, R01DA004398, R01DA011946)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- orexin-A, orexin, cocaine seeking, reinstatement of drug seeking, stress, noradrenergic system, corticotropin-releasing factor, intracranial self-stimulation, reward systems, addiction, footshock, SB-334867, lateral hypothalamus
- MeSH terms
- Orexins, Analysis of Variance, Animals, Benzoxazoles, Brain, Cocaine, Dose-Response Relationship, Drug, Male, Naphthyridines, Neuropeptides, Reward, Self Administration, Time Factors, Urea, Models, Statistical, Behavior, Addictive, Rats, Wistar, Cocaine-Related Disorders, Intracellular Signaling Peptides and Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.